Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In the latest session, Bristol-Myers Squibb Co (NYSE: BMY) closed at $48.94 down -0.59% from its previous closing price of $49.23. In other words, the price has decreased by -$0.59 from its previous closing price. On the day, 10.34 million shares were traded. BMY stock price reached its highest trading level at $49.6699 during the session, while it also had its lowest trading level at $48.16.
Ratios:
For a deeper understanding of Bristol-Myers Squibb Co’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.17 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.14. For the most recent quarter (mrq), Quick Ratio is recorded 1.15 and its Current Ratio is at 1.25. In the meantime, Its Debt-to-Equity ratio is 3.13 whereas as Long-Term Debt/Eq ratio is at 3.00.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 20 ’25 when BOERNER CHRISTOPHER S. bought 2,000 shares for $55.05 per share. The transaction valued at 110,096 led to the insider holds 104,626 shares of the business.
Hirawat Samit bought 1,823 shares of BMY for $100,000 on Feb 14 ’25. The EVP,Chief Med.Offr.,Drug Dev. now owns 63,932 shares after completing the transaction at $54.84 per share. On Nov 04 ’24, another insider, Holzer Phil M, who serves as the SVP and Controller of the company, sold 700 shares for $55.62 each. As a result, the insider received 38,930 and left with 11,760 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BMY now has a Market Capitalization of 100171366400 and an Enterprise Value of 139765530624. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.06 while its Price-to-Book (P/B) ratio in mrq is 6.08. Its current Enterprise Value per Revenue stands at 2.894 whereas that against EBITDA is 7.202.
Stock Price History:
The Beta on a monthly basis for BMY is 0.48, which has changed by -0.0010206103 over the last 52 weeks, in comparison to a change of 0.017286062 over the same period for the S&P500. Over the past 52 weeks, BMY has reached a high of $63.33, while it has fallen to a 52-week low of $39.35. The 50-Day Moving Average of the stock is -14.34%, while the 200-Day Moving Average is calculated to be -8.85%.
Shares Statistics:
For the past three months, BMY has traded an average of 12.88M shares per day and 16443210 over the past ten days. A total of 2.03B shares are outstanding, with a floating share count of 2.03B. Insiders hold about 0.08% of the company’s shares, while institutions hold 79.90% stake in the company. Shares short for BMY as of 1743379200 were 29399379 with a Short Ratio of 2.28, compared to 1740700800 on 30571531. Therefore, it implies a Short% of Shares Outstanding of 29399379 and a Short% of Float of 1.45000005.
Dividends & Splits
According to the company, the forward annual dividend rate for BMY is 2.44, from 2.42 in the trailing year. Against a Trailing Annual Dividend Yield of 0.04915702The stock’s 5-year Average Dividend Yield is 3.52.
